AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Pfizer, Roche, The COPD Foundation pulmonary news

The foundation launched the Chronic Obstructive Pulmonary Disease Biomarkers Qualification Consortium (CBQC). The consortium, which will include government agencies, academic institutions and pharmace...